# FDA recall D-0024-2019

> **Humco Holding Group, Inc** · Class II · drug recall initiated 2018-08-28.

## Product

Thyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain Liothyronine 29.2 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-6580-43 Packaged by: Humco Texarkana, TX 75501 USA

## Reason for recall

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

## Distribution

Nationwide.

## Key facts

- **Recall number:** D-0024-2019
- **Recalling firm:** Humco Holding Group, Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-08-28
- **Report date:** 2018-10-24
- **Termination date:** 2020-05-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Texarkana, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0024-2019

## Citation

> AI Analytics. FDA recall D-0024-2019. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0024-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*